Abstract
An enantioselective anion‐binding organocatalytic approach with versatile N,N‐dialkylhydrazones (DAHs) as polarity‐reversed (umpolung) nucleophiles is presented. For the application of this concept, a highly ordered hydrogen‐bond (HB) network between a carefully selected CF3‐substituted triazole‐based multidentate HB‐donor catalyst, the ionic substrate and the hydrazone in a supramolecular chiral ion‐pair complex was envisioned. The formation of such a network was further supported by both experimental and computational studies, which showed the crucial role of the anion as a template unit. The asymmetric Reissert‐type reaction of quinolines as a model test reaction chemoselectively delivered highly enantiomerically enriched hydrazones (up 95:5 e.r.) that could be further derivatized to value‐added compounds with up to three stereocenters.
Keywords: anion-binding catalysis, asymmetric catalysis, heterocycles, hydrazones, umpolung
Networking for success: N,N‐Dialkylhydrazones have been identified as versatile nucleophiles with multiple‐networking ability to enable self‐assembled chiral contact ion pair complexation for enantioselective anion‐binding catalysis. The resulting network of highly ordered noncovalent interactions with the anion as a central template motif led to high enantiomeric induction in a model Reissert‐type reaction with quinolines (see scheme).

The ability to efficiently synthesize enantioselective complex molecules employing simple modes of activation has long been considered an essential goal for asymmetric organocatalysis. [1] Among different approaches, enantioselective anion‐binding catalysis, [2] which is based on the activation of an ionic substrate towards nucleophilic attack upon binding the anion by a catalyst and formation of a chiral contact ion pair, has recently emerged as a powerful synthetic tool. Since the pioneering work by Jacobsen et al. [3] using chiral thioureas as hydrogen bond (HB) donor catalysts, [4] many applications have been reported in this field. [2] However, the implied noncovalent interactions for the anion recognition are less directional and more difficult to control than those implying covalent bonds. [5] For this reason, over the last few years there have been tremendous efforts for the design of new and original chiral catalysts [6] with the ability for multiple interactions to effectively spatially locate the reaction partners and, hence, achieve high stereochemical control with challenging reagents. [7] In this context, we have developed a novel family of chiral triazole‐based organocatalysts, [8] which present multicoordination sites, great modulating capacity and the flexible structure leading to a more effective fixation of the ionic substrates. In consequence, a highly chirality transfer has been achieved in a number of enantioselective reactions such as nucleophilic dearomatization of N‐ and O‐heteroarenes.[ 8 , 9 ] In fact, computational studies on the action of these catalysts have recently revealed an interesting role of the anion as bridging motif between the catalyst and polarized nucleophiles to achieve an effective orientation of the reactants. [10] This finding opens new possibilities by the careful choice of appropriate nucleophiles able to interact through H‐bonding with the anions of the contact ion‐pair complex.
Inspired by the anion‐binding properties of ammonium salts through H‐bonding with the C−H bonds alpha to the N atom and its reliable use in asymmetric catalysis, [11] we reasoned that N,N‐dialkylhydrazones (DAHs) could similarly interact with anions (Figure 1 a), providing a more rigid HB network and an efficient stereocontrol with such reagents. Moreover, hydrazones are considered an important building block in organic synthesis since they allow the introduction of a broad variety of functionalities in complex molecules. [12] Particularly, DAHs have acquired increasing interest in the past years due to their amphiphilic behavior at the azomethine carbon. [13] However, despite the versatility of these compounds exhibiting umpolung reactivity as nucleophilic reagents, until now only two different activation modes in organocatalysis, H‐bonding [4] and chiral counteranion catalysis [14] (Figure 1 b), have been efficiently employed. [15] In fact, the use of hydrazones as nucleophiles through an anion‐binding activation approach has only been recently envisioned. [16] Hence, we herein report on the first use of DAHs as suitable nucleophiles for anion‐binding catalysis by embracing an anion‐bridging strategy to allow for the facile and direct access to enantiomerically enriched adducts (Figure 1 c).
Figure 1.

Postulated anion‐binding properties and asymmetric organocatalytic umpolung approaches with N,N‐dialkylhydrazones (DAHs).
In order to evaluate our hypotheses, the enantioselective Reissert‐type dearomatization of quinolines was selected as model test reaction (Table 1).[ 8 , 17 ] We started our study by investigating the reaction of quinoline (2 a), 2,2,2‐trichloroethoxycarbonyl chloride (TrocCl) as acylating agent and the commercially available formaldehyde dimethylhydrazone 3 a as nucleophile, [18] in the presence of our most versatile triazole catalyst 1 a[ 8 , 9 , 10 ] (10 mol %) in toluene at −78 °C (entry 1). Although it proceeded with a complete regioselectivity to the desired 1,2‐addition product 4 a, an unexpected low enantioselectivity was observed. Bearing in mind the challenging stereocontrol with this type of hydrazones, we further envisaged the need of an additional fixation point of the nucleophile to the chiral catalyst. Thus, we replaced the alkyne substitution in 1 a for a CF3 group in 1 b, aiming at enhancing the catalyst polarization and anion‐binding affinity, as well as allowing a new F−H bond between this group at the catalyst and the carbonylic H atom of the formaldehyde hydrazone 3 a. As predicted, the enantioselectivity could be increased to 79:21 e.r. (entry 2).
Table 1.
Optimization screening for the model reaction with 2 a.[a]
|
Entry |
1 (mol %) |
Solvent |
T [°C] |
Yield [%][b] |
e.r.[c] |
|---|---|---|---|---|---|
|
1 |
1 a (10) |
toluene |
−78 |
74 |
65:35 |
|
2 |
1 b (10) |
toluene |
−78 |
87 |
79:21 |
|
3 |
1 b (10) |
toluene/C6F6 (3:1) |
0 |
79 |
81:19 |
|
4 |
1 c (10) |
toluene/C6F6 (3:1) |
0 |
76 |
63:37 |
|
5 |
1 d (10) |
toluene/C6F6 (3:1) |
0 |
88 |
72:28 |
|
6 |
1 e (10) |
toluene/C6F6 (3:1) |
0 |
87 |
74:26 |
|
7 |
1 f (10) |
toluene/C6F6 (3:1) |
0 |
69 |
51:49 |
|
8 |
1 h (10) |
toluene/C6F6 (3:1) |
0 |
79 |
50:50 |
|
9 |
1 i (10) |
toluene/C6F6 (3:1) |
0 |
79 |
52:48 |
|
10 |
1 j (10) |
toluene/C6F6 (3:1) |
0 |
92 |
51:49 |
|
11 |
1 g (10) |
toluene/C6F6 (3:1) |
0 |
90 |
88:12 |
|
12 |
1 g (10) |
C6F6 |
r.t. |
75 |
92:8[d] |
|
13 |
1 g (10) |
C6F6 |
4 |
84 |
94:6[d] |
|
14 |
1 g (5) |
C6F6 |
4 |
72 |
87:13[d] |
|
15 |
1 g (10) |
C6F6 |
4 |
80 |
92:8[d,e] |
[a] Reaction conditions: 2 a (1 equiv) and TrocCl (1 equiv) were stirred in the corresponding solvent (0.1 M) at 0 °C for 1 h; then the catalyst 1 and 3 a (2 equiv) were added at the appropriate temperature and left to react overnight. [b] Yield of the isolated product. [c] The enantiomeric ratio was determined by SFC on a chiral stationary phase. [d] Reaction using C6F6 dried over 4 Å MS and freshly distilled 2 a and 3 a. [e] Reaction performed at a concentration of 0.05 M.
At this point, based on the work of MacMillan and co‐workers, [19] we predicted that the use of perfluoroarenes as solvents should disfavor the possible cation π‐interactions between the corresponding quinolinium generated in the media and the solvent and, in consequence, an improvement in the enantioselectivity of the process should be observed. In fact, when a mixture of hexafluorobenzene (C6F6) and toluene was employed, the enantiomeric ratio was slightly enhanced to 81:19 e.r., allowing to perform the reaction at 0 °C (entry 3). Next, tetrakistriazole catalysts 1 c–f bearing different substituents at the aryl moiety were tested, providing good yields but lower enantioselectivities (entries 4–7), which supports the favorable effect of the CF3 substitution at this position. In other to further improve the enantioselectivity, other types of catalysts such as thioureas 1 h,i and squaramide 1 j were tested (entries 8–10). However, disappointing results were obtained with these stronger HB donors (<10 % ee), which should bind more tightly the chloride anion to form a chiral contact ion pair. Finally, the regioisomeric CF3‐tetrakistriazole 1 g was investigated since some reports on triazole anion receptors showed higher anion affinities with this type of isomers. [20] This structural change was translated to a further improvement on the enantioinduction, providing 4 a in 88:12 e.r. (entry 11), and 92:8 e.r. when only C6F6 was used at room temperature (entry 12). Finally, the use of freshly distilled C6F6 at 4 °C gave rise to the best enantiomeric ratio of 94:6 (entry 13).
With the optimized conditions in hand (see S.I. for a complete optimization study), catalyst 1 g (10 mol %) in C6F6 at 4 °C, the substrate scope on the hydrazone 3 was explored (Scheme 1). Symmetrically and nonsymmetrically substituted N,N‐dialkylhydrazones provided good yields and moderate to good enantioselectivities (4–7;9–11 a), while a substantial drop in the yield and a loss of enantioinduction was observed with an aromatic substitution (8 a). N‐Monoalkyl and C1‐substituted hydrazones led to no reactivity or undesired products such as N‐Troc‐ and 1,4‐addition adducts, respectively (see S.I.) Moreover, as is shown in the Scheme 1, the substitution on the N atom of the hydrazone affected significantly to the enantioselectivity, which is in line with our hypothesized participation of the N‐alkyl groups in the formation of the key chiral contact ion pair. Thus, the replacement of the methyl group for longer linear alkyl chains (6 a) or benzyl (7 a), and bulky groups such as iPr (5 a) or tBu (11 a) led to lower enantioselectivities (70:30–85:15 vs. 94:6 e.r.).
Scheme 1.

Screening of the substitution on the hydrazone 3.
Conversely, the employment of the freshly prepared 1‐piperidine and 1‐pyrrolidine hydrazones, gave rise the products 9 a and 10 a with good to excellent enantioselectivities (up to 95:5 e.r.). However, for practical reasons the subsequent investigations were mostly performed with the commercially available dimethyl hydrazone 3 a. Thus, the scope on the quinoline substrate 2 was carried out (Scheme 2). First of all, it is worthy to mention that the reaction could be conducted in an up to 2 mmol scale with no significant erosion in the activity or selectivity of the process (4 a; 79 %, 93:7 e.r.). The substitution at different positions of the quinoline was well tolerated, except for the C3 (4 d) and C8 positions (4 e) that led to significant lower enantioselectivity or no reaction, respectively. Moreover, the method showed a good functional group compatibility, allowing many groups such as halogens, methoxy, alkyl, alkenyl, alkynyl, nitro, amides or esters to give the products 4 f–s and 9 b,g,l,n (R′2=(CH2)5) in good to high enantioselectivities (up to 94:6 e.r.). Furthermore, the absolute configuration of the new stereocenter could be determined as (S) upon X‐ray structure analysis of the crystalline product 4 s. [21] It is especially remarkable the excellent chemoselectivity observed with quinolines substituted with an additional electrophilic species such as an aldehyde or a nitro‐Michael acceptor (4 t, 9 t and 4 u). In these cases, the reaction gave exclusively the 1,2‐addition product at the quinoline moiety within good enantioselectivities (up to 92:8 e.r.). Remarkably, the reaction also proceeded in the presence of a boronic ester, leading to the product 4 v with an 80:20 e.r. Lastly, phenanthridine, a diazarene and less reactive, more challenging pyridines could also be enrolled, leading to the hydrazone products 12–14 in up to 90:10 e.r.
Scheme 2.

Substrate scope. [a] Result of both 1 and 2 mmol reactions. [b] Reaction in Et2O at −78 °C for 2 days. Yields are for the isolated product.
The recyclability and stability of the catalysts was next explored in the prototypical reaction of 2 a, showing no degradation of the enantioselectivity up to three runs (Scheme 3, top). Afterwards, the synthetically value of the method and versatile chemistry of the products were illustrated by modifications of 4 a (Scheme 3, bottom). Hence, the chiral hydrazone could be easily transformed quantitatively upon acid treatment into the corresponding aldehyde 15, maintaining the enantiomeric purity, which was confirmed after reduction and cyclization to the cyclic carbamate 16. Moreover, 4 a was also converted into the cyanide 17 by treatment with magnesium monoperoxyphthalate (MMPP⋅6 H2O). The adduct 17 was then reduced to the tetrahydroquinoline 18, as well as further used as common precursor for the preparation of the corresponding aziridine 19 and epoxide 20 with complete diastereoselectivity and same high e.r., which were opened in a completely regioselective manner with MeOH in acid media to provide highly decorated chiral tetrahydroquinolines (21 and 22) within three stereocenters. Lastly, the possibility of N‐Troc group deprotection was demonstrated by treating 22 with Zn/AcOH, leading to the desired NH‐free derivative 23.
Scheme 3.

Recycling of the catalyst 1 g and synthetic applications.
Lastly, aiming at gaining insight into the key interactions within the catalyst 1 g and the mechanism of the reaction, the standard reaction of 2 a and TrocCl with hydrazone 3 a was investigated in more detail (Figure 2). The monitoring of the reaction course was performed at room temperature in an NMR tube in C6F6/[D8]toluene (4:1) due to solubility issues (Figure 2 a, see S.I.). This revealed a fast transformation, requiring just 1 h to reach 4 a in approximately 60 % yield (6 h, 76 %) and 5 min or less for the final enantioselectivity of 92:8 e.r. Moreover, the chloride anion affinity of the catalyst 1 g was determined by NMR titration with tetrabutylammonium chloride (TBACl) as chloride source in a constant [2 mM] of 1 g (see S.I. for details). As predicted, the central CF3 groups boosted the affinity to approximately 3100 M−1 (and ca. 1875 M−1 for its regioisomer 1 b vs. ca. 500 M−1 for 1 a). [10] Based on that, a plausible mechanism considering the formation of a tight catalyst:substrate contact ion pair complex is shown in Figure 2 b. Hence, the real substrate quinolinium salt I is formed in situ by treatment of 2 a with TrocCl. This species forms a chiral contact ion pair II with the catalyst 1 g. Then, the nucleophilic attack of the hydrazone 3 a delivers the intermediate III, which provides the final product upon deprotonation by Cl− or another molecule of 3 a, with concomitant formal elimination of HCl and regeneration of the catalyst 1 g. [18] Finally, the transition state (TS) of the reaction was computed at DFT‐B3LYP [23] ‐GD3BJ [24] /def2tzvp [25] //AM1 [26] level of theory including the solvent effect (C6F6) with COSMOS‐RS [27] at BP86 [28] /def2tzvp (Figure 2 c, see S.I. for more details). The 1 g:Cl− complex in I is stabilized by four HBs between Cl− and the C−H bonds of the central triazoles and arenes. Moreover, the approach of the nucleophile 3 a is directed by a F−H bond between a CF3 group of 1 g and a carbonyl H of 3 a. In the TS, however, only one arms of the catalyst participates in the HB interactions with Cl−, while additional stabilization through F−H bonds with the CF3 group and both the substrate and 3 a, as well as a Cl–π interaction between the Troc group and the other arm of the catalyst, takes place. The nucleophilic addition involves a small barrier of 2.7 kcal mol−1, leading to the more stable intermediate III (−13.5 kcal mol−1) that further evolves to the final product 4 a. Moreover, the H‐bonding network and preorientation in the TS explained a more favorable Si‐face attack and the observed absolute configuration (S) of the product.
Figure 2.

a) Reaction monitoring and binding constant for 1 g:Cl−, [22] b) proposed mechanism, and c) computed TS for the model reaction of 2 a with 3 a in C6F6 at room temperature (zoom‐in: F–H (red), CH–Cl (black), and Cl–π interactions (blue); new C−C bond (gray)). See the Supporting Information for details.
In conclusion, an enantioselective umpolung nucleophilic addition of formaldehyde N,N‐dialkylhydrazones to quinolinium chloride salts embracing a novel catalytic anion‐binding approach has been developed. The synthetic versatility of the method was also demonstrated by derivatization of the obtained chiral hydrazones into value‐added heterocyclic compounds with up to three stereocenters. The use of a multidentate triazole‐based H‐donor as catalyst bearing CF3 groups in the central aromatic units allows for the formation of a supramolecular tight chiral contact ion pair complex by a highly ordered HB network between the catalyst, ionic substrate and nucleophilic hydrazone to ensure a high enantioselectivity even at room temperature. Based on experimental and computational observations, the chloride anion has an important role as it acts as junction between all components of the reaction. Moreover, the nature of N‐alkyl group on the hydrazone is also crucial, since it participates in the HB network in the TS to fix the reagent. Further catalytic strategies based on such anion‐templated HB assemblies are currently being investigated in our group.
Conflict of interest
The authors declare no conflict of interest.
Supporting information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supplementary
Acknowledgements
The European Research Council (ERC‐CG 724695) and the Deutsche Forschungsgemeinschaft (DFG) within the SFB858 are gratefully acknowledged for generous support. We thank L. Schifferer for providing some catalysts precursors. Open access funding enabled and organized by Projekt DEAL.
M. Gómez-Martínez, M. del Carmen Pérez-Aguilar, D. G. Piekarski, C. G. Daniliuc, O. García Mancheño, Angew. Chem. Int. Ed. 2021, 60, 5102.
References
- 1.“Activation Modes in Asymmetric Organocatalysis”: Moyano A., Stereoselective Organocatalysis (Ed.: Rios Torres R.), Wiley, Hoboken, 2013, pp. 11–80. [Google Scholar]
- 2.For selected reviews, see:
- 2a. Zhang Z., Schreiner P. R., Chem. Soc. Rev. 2009, 38, 1187–1198; [DOI] [PubMed] [Google Scholar]
- 2b. Phipps R. J., Hamilton G. L., Toste F. D., Nat. Chem. 2012, 4, 603–614; [DOI] [PubMed] [Google Scholar]
- 2c. Beckendorf S., Asmus S., García Mancheño O., ChemCatChem 2012, 4, 926–936; [Google Scholar]
- 2d. Mahlau M., List B., Angew. Chem. Int. Ed. 2013, 52, 518–533; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 540–556; [Google Scholar]
- 2e. Brak K., Jacobsen E. N., Angew. Chem. Int. Ed. 2013, 52, 534–561; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 558–588; [Google Scholar]
- 2f. Seidel D., Synlett 2014, 25, 783–794; [Google Scholar]
- 2g. Visco M. D., Attard J., Guan Y., Mattson A. E., Tetrahedron Lett. 2017, 58, 2623–2684. [Google Scholar]
- 3.For pioneering studies, see:
- 3a. Taylor M. S., Jacobsen E. N., J. Am. Chem. Soc. 2004, 126, 10558–10559; [DOI] [PubMed] [Google Scholar]
- 3b. Raheem I. T., Thiara P. S., Peterson E. A., Jacobsen E. N., J. Am. Chem. Soc. 2007, 129, 13404–13405. [DOI] [PubMed] [Google Scholar]
- 4.For selected reviews on HB-donor catalysis, see:
- 4a. Schreiner P. R., Chem. Soc. Rev. 2003, 32, 289–296; [DOI] [PubMed] [Google Scholar]
- 4b. Pihko P. M., Angew. Chem. Int. Ed. 2004, 43, 2062–2064; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2004, 116, 2110–2113; [Google Scholar]
- 4c. Taylor M. S., Jacobsen E. N., Angew. Chem. Int. Ed. 2006, 45, 1520–1543; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2006, 118, 1550–1573; [Google Scholar]
- 4d. Doyle A. G., Jacobsen E. N., Chem. Rev. 2007, 107, 5713–5743; [DOI] [PubMed] [Google Scholar]
- 4e. Pihko P. M., Hydrogen Bonding in Organic Chemistry, Wiley-VCH, Weinheim, 2009; [Google Scholar]
- 4f. Jacobsen E. N., Knowles R. R., Proc. Natl. Acad. Sci. USA 2010, 107, 20678–20685; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4g. Nishikawa Y., Tetrahedron Lett. 2018, 59, 216–223. [Google Scholar]
- 5.For selected reviews of covalent activation modes, see:
- 5a. List B., Tetrahedron 2002, 58, 5590; [Google Scholar]
- 5b. Palomo C., Mielgo A., Angew. Chem. Int. Ed. 2006, 45, 7876–7880; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2006, 118, 8042–8046; [Google Scholar]
- 5c. Mukherjee S., Yang J. W., Hoffmann S., List B., Chem. Rev. 2007, 107, 5471–5569; [DOI] [PubMed] [Google Scholar]
- 5d. Mielgo A., Palomo C., Chem. Asian J. 2008, 3, 922–948. [DOI] [PubMed] [Google Scholar]
- 6.For selected examples, see:
- 6a. Schafer A. G., Wieting J. M., Fisher T. J., Mattson A. E., Angew. Chem. Int. Ed. 2013, 52, 11321–11324; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 11531–11534; [Google Scholar]
- 6b. Attard J., Osawa K., Guan Y., Hatt J., Kondo S., Mattson A. E., Synthesis 2019, 51, 2107–2115; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6c. Park Y., Harper K. C., Kuhl N., Kwan E. E., Liu R. Y., Jacobsen E. N., Science 2017, 355, 162–166; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6d. Eichstaedt K., Jaramillo-Garcia J., Leigh D. A., Marcos V., Pisano S., Singleton T. A., J. Am. Chem. Soc. 2017, 139, 9376–9381. [DOI] [PubMed] [Google Scholar]
- 7.For selected examples, see:
- 7a. Beletskiy E. V., Schmidt J., Wang X.-B., Kass S. R., J. Am. Chem. Soc. 2012, 134, 18534–18537; [DOI] [PubMed] [Google Scholar]
- 7b. Borovika A., Tang P.-I., Klapman S., Nagorny P., Angew. Chem. Int. Ed. 2013, 52, 13424–13428; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 13666–13670; [Google Scholar]
- 7c. Ford D. D., Lehnherr D., Kennedy C. R., Jacobsen E. N., J. Am. Chem. Soc. 2016, 138, 7860–7863; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7d. Mayfield A. B., Metternich J. B., Trotta A. H., Jacobsen E. N., J. Am. Chem. Soc. 2020, 142, 4061–4069; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7e. Ning R., Zhou H., Nie S.-X., Ao Y.-F., Wang D.-X., Wang Q.-Q., Angew. Chem. Int. Ed. 2020, 59, 10894–10898; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2020, 132, 10986–10990. [Google Scholar]
- 8. Zurro M., Asmus S., Beckendorf S., Mück-Lichtenfeld C., García Mancheño O., J. Am. Chem. Soc. 2014, 136, 13999–14002. [DOI] [PubMed] [Google Scholar]
- 9.
- 9a. García Mancheño O., Asmus S., Zurro M., Fischer T., Angew. Chem. Int. Ed. 2015, 54, 8823–8827; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2015, 127, 8947–8951; [Google Scholar]
- 9b. Zurro M., Asmus S., Bamberger J., Beckendorf S., García Mancheño O., Chem. Eur. J. 2016, 22, 3785–3793; [DOI] [PubMed] [Google Scholar]
- 9c. Fischer T., Duong Q.-N., García Mancheño O., Chem. Eur. J. 2017, 23, 5983–5987; [DOI] [PubMed] [Google Scholar]
- 9d. Zurro M., García Mancheño O., Chem. Rec. 2017, 17, 485–498; [DOI] [PubMed] [Google Scholar]
- 9e. Duong Q.-N., Schifferer L., García Mancheño O., Eur. J. Org. Chem. 2019, 5452–5461; [Google Scholar]
- 9f. Fischer T., Bamberger J., Gómez-Martínez M., Piekarski D. G., García Mancheño O., Angew. Chem. Int. Ed. 2019, 58, 3217–3221; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2019, 131, 3250–3255. [Google Scholar]
- 10. Piekarski D. G., Steinforth P., Gómez-Martínez M., Bamberger J., Ostler F., Schönhoff M., García Mancheño O., Chem. Eur. J. 2020, 26, 17598–17603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.For pioneering studies, see: Shirakawa S., Liu S., Kaneko S., Kumatabara Y., Fukuda A., Omagari Y., Maruoka K., Angew. Chem. Int. Ed. 2015, 54, 15767–15770; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2015, 127, 15993–15996; for a review, see: [Google Scholar]; Nakamura T., Okuno K., Nishiyori R., Shirakawa S., Chem. Asian J. 2020, 15, 463–472. [DOI] [PubMed] [Google Scholar]
- 12.For hydrazones in synthesis, see:
- 12a. Kim S., Yoon J.-Y. in Science of Synthesis, Vol. 27 (Eds: Padwa A.), Georg Thieme, Stuttgart, 2004, pp. 671–722; for the bioactivity of the hydrazones, see: [Google Scholar]
- 12b. Xavier A., Thakur M., Thakur M., Marie J., J. Chem. Pharm. Res. 2012, 4, 986–990; [Google Scholar]
- 12c. Verma G., Marella A., Shaquiquzzaman M., Akhtar M., Ali M. R., Alam M. M., J. Pharm. BioAllied. Sci. 2014, 6, 69–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.For pioneering studies using DAHs in organocatalysis, see:
- 13a. Brehme R., Tetrahedron Lett. 1982, 23, 1131–1134; for selected reviews about hydrazones in asymmetric organocatalysis, see: [Google Scholar]
- 13b. Fernández R., Lassaletta J. M., Synlett 2000, 1228–1240; [Google Scholar]
- 13c. Brehme R., Enders D., Fernandez R., Lassaletta J. M., Eur. J. Org. Chem. 2007, 5629–5660; [Google Scholar]
- 13d. Lazny R., Nodzewska A., Chem. Rev. 2010, 110, 1386–1434; [DOI] [PubMed] [Google Scholar]
- 13e. de Gracia Retamosa M., Matador E., Monge D., Lassaletta J. M., Fernández R., Chem. Eur. J. 2016, 22, 13430–13445; for selected studies using DAHs in metal catalysis, see: [DOI] [PubMed] [Google Scholar]
- 13f. Rueping M., Sudan Maji M., Bas H., Küçük P., Atodiresei I., Angew. Chem. Int. Ed. 2012, 51, 12864–12868; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2012, 124, 13036–13040; [Google Scholar]
- 13g. Soldi C., Lamb K. N., Squitieri R. A., González-López M., Di Maso M. J., Shaw J. T., J. Am. Chem. Soc. 2014, 136, 15142–15145; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13h. Breitler S., Carreira E. M., J. Am. Chem. Soc. 2015, 137, 5296–5299; [DOI] [PubMed] [Google Scholar]
- 13i. Pang Y., He Q., Li Z.-Q., Yang J.-M., Yu J.-H., Zhu S.-F., Zhou Q.-L., J. Am. Chem. Soc. 2018, 140, 10663–10668; [DOI] [PubMed] [Google Scholar]
- 13j. Choi K., Park H., Lee C., J. Am. Chem. Soc. 2018, 140, 10407–10411. [DOI] [PubMed] [Google Scholar]
- 14.For reviews on chiral counteranion catalysis, see:
- 14a. Mahlau M., List B. in Asymmetric Synthesis II (Eds: Christmann M., Bräse S.), 2012, pp. 79–85; [Google Scholar]
- 14b. Ávila E. P., Amarante G. W., ChemCatChem 2012, 4, 1713–1721; see also Ref. [2d]. [Google Scholar]
- 15.For selected examples of HB-donor catalysis employing DAHs, see:
- 15a. Dixon D. J., Tillman A. L., Synlett 2005, 2635–2638; [Google Scholar]
- 15b. Pettersen D., Herrera R. P., Bernardi L., Fini F., Sgarzani V., Fernandez R., Lassaletta J. M., Ricci A., Synlett 2006, 239–242; [Google Scholar]
- 15c. Herrera R. P., Monge D., Martín-Zamora E., Fernández R., Lassaletta J. M., Org. Lett. 2007, 9, 3303–3306; [DOI] [PubMed] [Google Scholar]
- 15d. Hashimoto T., Hirose M., Maruoka K., J. Am. Chem. Soc. 2008, 130, 7556–7557; [DOI] [PubMed] [Google Scholar]
- 15e. Hashimoto T., Kimura H., Maruoka K., Angew. Chem. Int. Ed. 2010, 49, 6844–6847; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2010, 122, 6996–6999; Selected examples of DAHs in organocatalysis: [Google Scholar]
- 15f. Rueping M., Sugiono E., Theissmann T., Kuenkel A., Köckritz A., Pews-Davtyan A., Nemati N., Beller M., Org. Lett. 2007, 9, 1065–1068; [DOI] [PubMed] [Google Scholar]
- 15g. Wang Y., Wang Q., Zhu J., Angew. Chem. Int. Ed. 2017, 56, 5612; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2017, 129, 5704; [Google Scholar]
- 15h. Zabaleta N., Uria U., Reyes E., Carrillo L., Vicario J. L., Chem. Commun. 2018, 54, 8905–8908. [DOI] [PubMed] [Google Scholar]
- 16.During the preparation of this manuscript, a complementary related method with isoquinolines and NHtBu-hydrazones for the formation of chiral azo derivatives appeared: Matador E., Iglesias-Sigüenza J., Monge D., Merino P., Fernández R., Lassaletta J. M., Angew. Chem. Int. Ed. 2020, 10.1002/anie.202012861; [DOI] [Google Scholar]; Angew. Chem. 2020, 10.1002/ange.202012861. [DOI] [Google Scholar]
- 17.For selected examples of Reissert-type reactions promoted by anion-binding catalysis, see:
- 17a. Taylor M. S., Tokunaga N., Jacobsen E. N., Angew. Chem. Int. Ed. 2005, 44, 6700–6704; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2005, 117, 6858–6862; [Google Scholar]
- 17b. Frisch K., Landa A., Saaby S., Jørgensen K. A., Angew. Chem. Int. Ed. 2005, 44, 6058–6063; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2005, 117, 6212–6217; [Google Scholar]
- 17c. Yamaoka Y., Miyabe H., Takemoto Y., J. Am. Chem. Soc. 2007, 129, 6686–6687; [DOI] [PubMed] [Google Scholar]
- 17d.Ref. [2a];
- 17e. Ray Choudhury A., Mukherjee S., Chem. Sci. 2016, 7, 6940–6945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.We used 2 equivalents of 3 to achieve faster, cleaner and higher yielding reactions (e.g. 97 %, 87:13 e.r vs. 68 %, 88:12 e.r. with 1.05 equiv 3 a, see Table S1). The use of stoichiometric 3 led to no poisoning of the catalyst by the HCl formed in situ, since it is also quenched by the product.
- 19.
- 19a. Liu C., Oblak Z., Wal M. N. V., Dilger A. K., Almstead D. K., MacMillan D. W. C., J. Am. Chem. Soc. 2016, 138, 2134–2137; for studies on cation–π interactions, see: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19b. Ma J. C., Dougherty D. A., Chem. Rev. 1997, 97, 1303–1324; [DOI] [PubMed] [Google Scholar]
- 19c. Dougherty D. A., Science 1996, 271, 163–168. [DOI] [PubMed] [Google Scholar]
- 20.See, for example:
- 20a. Juwarker H., Lenhardt J. M., Pham D. M., Craig S. L., Angew. Chem. Int. Ed. 2008, 47, 3740–3743; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2008, 120, 3800–3803; [Google Scholar]
- 20b. Li Y., Flood A. H., Angew. Chem. Int. Ed. 2008, 47, 2649–2652; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2008, 120, 2689–2692; [Google Scholar]
- 20c. Hua Y., Flood A. H., Chem. Soc. Rev. 2010, 39, 1262–1271. [DOI] [PubMed] [Google Scholar]
- 21. Deposition Number 2034269 (for (S)-4s) contains the supplementary crystallographic data for this paper. These data are provided free of charge by the joint Cambridge Crystallographic Data Centre and Fachinformationszentrum Karlsruhe Access Structures service www.ccdc.cam.ac.uk/structures. See also the S.I. for the X-ray crystal structure.
- 22.The binding constant was determined using the program BindFit v0.5, available at http://app.supramolecular.org/bindfit.
- 23. Becke A. D., J. Chem. Phys. 1993, 98, 5648–5652. [Google Scholar]
- 24. Grimme S., Ehrlich S., Goerigk L., J. Comput. Chem. 2011, 32, 1456–1465. [DOI] [PubMed] [Google Scholar]
- 25. Schäfer A., Huber C., Ahlrichs R., J. Chem. Phys. 1994, 100, 5829–5835. [Google Scholar]
- 26. Dewar M. J. S., Zoebisch E. G., Healy E. F., J. Am. Chem. Soc. 1985, 107, 3902–3909. [Google Scholar]
- 27.
- 27a.COSMOtherm, Version C3.0, Release 17.01; COSMOlogic GmbH and Co. KG, http://www.cosmologic.de;
- 27b. Klamt A., J. Phys. Chem. 1995, 99, 2224–2235. [Google Scholar]
- 28.
- 28a. Becke A. D., Phys. Rev. A 1988, 38, 3098–3100; [DOI] [PubMed] [Google Scholar]
- 28b. Perdew J. P., Phys. Rev. B 1986, 33, 8822–8824. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supplementary
